Anticholinergics versus placebo for neuroleptic-induced parkinsonism

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of anticholinergic drugs compared with placebo for antipsychotic-induced parkinsonism in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder.